521 related articles for article (PubMed ID: 27769711)
1. Esculetin prevents non-alcoholic fatty liver in diabetic mice fed high-fat diet.
Choi RY; Ham JR; Lee MK
Chem Biol Interact; 2016 Dec; 260():13-21. PubMed ID: 27769711
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of esculetin on hyperglycemia-mediated oxidative damage in the hepatic and renal tissues of experimental diabetic rats.
Prabakaran D; Ashokkumar N
Biochimie; 2013 Feb; 95(2):366-73. PubMed ID: 23079336
[TBL] [Abstract][Full Text] [Related]
3. Scopoletin Supplementation Ameliorates Steatosis and Inflammation in Diabetic Mice.
Choi RY; Ham JR; Lee HI; Cho HW; Choi MS; Park SK; Lee J; Kim MJ; Seo KI; Lee MK
Phytother Res; 2017 Nov; 31(11):1795-1804. PubMed ID: 28921708
[TBL] [Abstract][Full Text] [Related]
4. Myricitrin Ameliorates Hyperglycemia, Glucose Intolerance, Hepatic Steatosis, and Inflammation in High-Fat Diet/Streptozotocin-Induced Diabetic Mice.
Kim DY; Kim SR; Jung UJ
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182914
[TBL] [Abstract][Full Text] [Related]
5. Wild ginseng cambial meristematic cells ameliorate hepatic steatosis and mitochondrial dysfunction in high-fat diet-fed mice.
Lee SB; Cho HI; Jin YW; Lee EK; Ahn JY; Lee SM
J Pharm Pharmacol; 2016 Jan; 68(1):119-27. PubMed ID: 26806698
[TBL] [Abstract][Full Text] [Related]
6. Ameliorative effects of lutein on non-alcoholic fatty liver disease in rats.
Qiu X; Gao DH; Xiang X; Xiong YF; Zhu TS; Liu LG; Sun XF; Hao LP
World J Gastroenterol; 2015 Jul; 21(26):8061-72. PubMed ID: 26185377
[TBL] [Abstract][Full Text] [Related]
7. Pu-erh tea extract ameliorates high-fat diet-induced nonalcoholic steatohepatitis and insulin resistance by modulating hepatic IL-6/STAT3 signaling in mice.
Cai X; Fang C; Hayashi S; Hao S; Zhao M; Tsutsui H; Nishiguchi S; Sheng J
J Gastroenterol; 2016 Aug; 51(8):819-29. PubMed ID: 26794005
[TBL] [Abstract][Full Text] [Related]
8. Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese mice.
Sun H; Wang X; Chen J; Song K; Gusdon AM; Li L; Bu L; Qu S
Lipids Health Dis; 2016 Nov; 15(1):202. PubMed ID: 27876064
[TBL] [Abstract][Full Text] [Related]
9. Garcinia Cambogia attenuates diet-induced adiposity but exacerbates hepatic collagen accumulation and inflammation.
Kim YJ; Choi MS; Park YB; Kim SR; Lee MK; Jung UJ
World J Gastroenterol; 2013 Aug; 19(29):4689-701. PubMed ID: 23922466
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol attenuates hepatic steatosis in high-fat fed mice by decreasing lipogenesis and inflammation.
Andrade JM; Paraíso AF; de Oliveira MV; Martins AM; Neto JF; Guimarães AL; de Paula AM; Qureshi M; Santos SH
Nutrition; 2014; 30(7-8):915-9. PubMed ID: 24985011
[TBL] [Abstract][Full Text] [Related]
11. Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway.
Pandey A; Raj P; Goru SK; Kadakol A; Malek V; Sharma N; Gaikwad AB
Pharmacol Rep; 2017 Aug; 69(4):666-672. PubMed ID: 28527877
[TBL] [Abstract][Full Text] [Related]
12. Canagliflozin protects against non-alcoholic steatohepatitis in type-2 diabetic rats through zinc alpha-2 glycoprotein up-regulation.
Kabil SL; Mahmoud NM
Eur J Pharmacol; 2018 Jun; 828():135-145. PubMed ID: 29608898
[TBL] [Abstract][Full Text] [Related]
13. Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease.
Li DJ; Liu J; Hua X; Fu H; Huang F; Fei YB; Lu WJ; Shen FM; Wang P
Metabolism; 2018 Feb; 79():52-63. PubMed ID: 29129819
[TBL] [Abstract][Full Text] [Related]
14. Fish oil alleviated high-fat diet-induced non-alcoholic fatty liver disease via regulating hepatic lipids metabolism and metaflammation: a transcriptomic study.
Yuan F; Wang H; Tian Y; Li Q; He L; Li N; Liu Z
Lipids Health Dis; 2016 Feb; 15():20. PubMed ID: 26832365
[TBL] [Abstract][Full Text] [Related]
15. Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.
Tsujimoto S; Kishina M; Koda M; Yamamoto Y; Tanaka K; Harada Y; Yoshida A; Hisatome I
Int J Mol Med; 2016 Sep; 38(3):721-8. PubMed ID: 27431935
[TBL] [Abstract][Full Text] [Related]
16. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
Dwivedi DK; Jena GB
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
[TBL] [Abstract][Full Text] [Related]
17. Oxymatrine alleviates high-fat diet/streptozotocin-induced non-alcoholic fatty liver disease in C57BL/6 J mice by modulating oxidative stress, inflammation and fibrosis.
Lou D; Fang Q; He Y; Ma R; Wang X; Li H; Qi M
Biomed Pharmacother; 2024 May; 174():116491. PubMed ID: 38537582
[TBL] [Abstract][Full Text] [Related]
18. Effects of Callistephus chinensis flower polyphones on improving metabolic disorders in high-fat diet-induced mice.
Bi X; Liu W; Xia X; Chen L; Mu T; Liu J; Hou Y; Zhao Y
Food Funct; 2014 Dec; 5(12):3304-10. PubMed ID: 25367327
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of various ratios of DHA/EPA supplementation on high-fat diet-induced liver damage in mice.
Shang T; Liu L; Zhou J; Zhang M; Hu Q; Fang M; Wu Y; Yao P; Gong Z
Lipids Health Dis; 2017 Mar; 16(1):65. PubMed ID: 28356106
[TBL] [Abstract][Full Text] [Related]
20. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
